Global Immune Globulin Intravenous Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Immune Globulin Intravenous market size was valued at US$ 13070 million in 2023. With growing demand in downstream market, the Immune Globulin Intravenous is forecast to a readjusted size of US$ 21490 million by 2030 with a CAGR of 7.4% during review period.
The research report highlights the growth potential of the global Immune Globulin Intravenous market. Immune Globulin Intravenous are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Immune Globulin Intravenous. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Immune Globulin Intravenous market.
Immune globulin (Ig) short-term protection against hepatitis A and measles
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
Key Features:
The report on Immune Globulin Intravenous market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Immune Globulin Intravenous market. It may include historical data, market segmentation by Type (e.g., IVIg Liquid, IVIg Powder), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Immune Globulin Intravenous market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Immune Globulin Intravenous market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Immune Globulin Intravenous industry. This include advancements in Immune Globulin Intravenous technology, Immune Globulin Intravenous new entrants, Immune Globulin Intravenous new investment, and other innovations that are shaping the future of Immune Globulin Intravenous.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Immune Globulin Intravenous market. It includes factors influencing customer ' purchasing decisions, preferences for Immune Globulin Intravenous product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Immune Globulin Intravenous market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Immune Globulin Intravenous market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Immune Globulin Intravenous market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Immune Globulin Intravenous industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Immune Globulin Intravenous market.
Market Segmentation:
Immune Globulin Intravenous market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Immune Globulin Intravenous market?
What factors are driving Immune Globulin Intravenous market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Immune Globulin Intravenous market opportunities vary by end market size?
How does Immune Globulin Intravenous break out type, application?
According to our LPI (LP Information) latest study, the global Immune Globulin Intravenous market size was valued at US$ 13070 million in 2023. With growing demand in downstream market, the Immune Globulin Intravenous is forecast to a readjusted size of US$ 21490 million by 2030 with a CAGR of 7.4% during review period.
The research report highlights the growth potential of the global Immune Globulin Intravenous market. Immune Globulin Intravenous are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Immune Globulin Intravenous. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Immune Globulin Intravenous market.
Immune globulin (Ig) short-term protection against hepatitis A and measles
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
Key Features:
The report on Immune Globulin Intravenous market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Immune Globulin Intravenous market. It may include historical data, market segmentation by Type (e.g., IVIg Liquid, IVIg Powder), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Immune Globulin Intravenous market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Immune Globulin Intravenous market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Immune Globulin Intravenous industry. This include advancements in Immune Globulin Intravenous technology, Immune Globulin Intravenous new entrants, Immune Globulin Intravenous new investment, and other innovations that are shaping the future of Immune Globulin Intravenous.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Immune Globulin Intravenous market. It includes factors influencing customer ' purchasing decisions, preferences for Immune Globulin Intravenous product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Immune Globulin Intravenous market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Immune Globulin Intravenous market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Immune Globulin Intravenous market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Immune Globulin Intravenous industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Immune Globulin Intravenous market.
Market Segmentation:
Immune Globulin Intravenous market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- IVIg Liquid
- IVIg Powder
- Immunodeficiency
- Autoimmune Disease
- Acute Infection
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda
- Grifols
- CSL
- Octapharma
- Biotest
- Kedrion
- Hualan Bio
- CNBG
- Shanghai RAAS
- CBPO
- LFB Group
- BPL
- Sichuan Yuanda Shuyang
What is the 10-year outlook for the global Immune Globulin Intravenous market?
What factors are driving Immune Globulin Intravenous market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Immune Globulin Intravenous market opportunities vary by end market size?
How does Immune Globulin Intravenous break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immune Globulin Intravenous Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Immune Globulin Intravenous by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Immune Globulin Intravenous by Country/Region, 2019, 2023 & 2030
2.2 Immune Globulin Intravenous Segment by Type
2.2.1 IVIg Liquid
2.2.2 IVIg Powder
2.3 Immune Globulin Intravenous Sales by Type
2.3.1 Global Immune Globulin Intravenous Sales Market Share by Type (2019-2024)
2.3.2 Global Immune Globulin Intravenous Revenue and Market Share by Type (2019-2024)
2.3.3 Global Immune Globulin Intravenous Sale Price by Type (2019-2024)
2.4 Immune Globulin Intravenous Segment by Application
2.4.1 Immunodeficiency
2.4.2 Autoimmune Disease
2.4.3 Acute Infection
2.5 Immune Globulin Intravenous Sales by Application
2.5.1 Global Immune Globulin Intravenous Sale Market Share by Application (2019-2024)
2.5.2 Global Immune Globulin Intravenous Revenue and Market Share by Application (2019-2024)
2.5.3 Global Immune Globulin Intravenous Sale Price by Application (2019-2024)
3 GLOBAL IMMUNE GLOBULIN INTRAVENOUS BY COMPANY
3.1 Global Immune Globulin Intravenous Breakdown Data by Company
3.1.1 Global Immune Globulin Intravenous Annual Sales by Company (2019-2024)
3.1.2 Global Immune Globulin Intravenous Sales Market Share by Company (2019-2024)
3.2 Global Immune Globulin Intravenous Annual Revenue by Company (2019-2024)
3.2.1 Global Immune Globulin Intravenous Revenue by Company (2019-2024)
3.2.2 Global Immune Globulin Intravenous Revenue Market Share by Company (2019-2024)
3.3 Global Immune Globulin Intravenous Sale Price by Company
3.4 Key Manufacturers Immune Globulin Intravenous Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immune Globulin Intravenous Product Location Distribution
3.4.2 Players Immune Globulin Intravenous Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IMMUNE GLOBULIN INTRAVENOUS BY GEOGRAPHIC REGION
4.1 World Historic Immune Globulin Intravenous Market Size by Geographic Region (2019-2024)
4.1.1 Global Immune Globulin Intravenous Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Immune Globulin Intravenous Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Immune Globulin Intravenous Market Size by Country/Region (2019-2024)
4.2.1 Global Immune Globulin Intravenous Annual Sales by Country/Region (2019-2024)
4.2.2 Global Immune Globulin Intravenous Annual Revenue by Country/Region (2019-2024)
4.3 Americas Immune Globulin Intravenous Sales Growth
4.4 APAC Immune Globulin Intravenous Sales Growth
4.5 Europe Immune Globulin Intravenous Sales Growth
4.6 Middle East & Africa Immune Globulin Intravenous Sales Growth
5 AMERICAS
5.1 Americas Immune Globulin Intravenous Sales by Country
5.1.1 Americas Immune Globulin Intravenous Sales by Country (2019-2024)
5.1.2 Americas Immune Globulin Intravenous Revenue by Country (2019-2024)
5.2 Americas Immune Globulin Intravenous Sales by Type
5.3 Americas Immune Globulin Intravenous Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immune Globulin Intravenous Sales by Region
6.1.1 APAC Immune Globulin Intravenous Sales by Region (2019-2024)
6.1.2 APAC Immune Globulin Intravenous Revenue by Region (2019-2024)
6.2 APAC Immune Globulin Intravenous Sales by Type
6.3 APAC Immune Globulin Intravenous Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Immune Globulin Intravenous by Country
7.1.1 Europe Immune Globulin Intravenous Sales by Country (2019-2024)
7.1.2 Europe Immune Globulin Intravenous Revenue by Country (2019-2024)
7.2 Europe Immune Globulin Intravenous Sales by Type
7.3 Europe Immune Globulin Intravenous Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immune Globulin Intravenous by Country
8.1.1 Middle East & Africa Immune Globulin Intravenous Sales by Country (2019-2024)
8.1.2 Middle East & Africa Immune Globulin Intravenous Revenue by Country (2019-2024)
8.2 Middle East & Africa Immune Globulin Intravenous Sales by Type
8.3 Middle East & Africa Immune Globulin Intravenous Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immune Globulin Intravenous
10.3 Manufacturing Process Analysis of Immune Globulin Intravenous
10.4 Industry Chain Structure of Immune Globulin Intravenous
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immune Globulin Intravenous Distributors
11.3 Immune Globulin Intravenous Customer
12 WORLD FORECAST REVIEW FOR IMMUNE GLOBULIN INTRAVENOUS BY GEOGRAPHIC REGION
12.1 Global Immune Globulin Intravenous Market Size Forecast by Region
12.1.1 Global Immune Globulin Intravenous Forecast by Region (2025-2030)
12.1.2 Global Immune Globulin Intravenous Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Immune Globulin Intravenous Forecast by Type
12.7 Global Immune Globulin Intravenous Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Immune Globulin Intravenous Product Portfolios and Specifications
13.1.3 Takeda Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Immune Globulin Intravenous Product Portfolios and Specifications
13.2.3 Grifols Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Immune Globulin Intravenous Product Portfolios and Specifications
13.3.3 CSL Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Immune Globulin Intravenous Product Portfolios and Specifications
13.4.3 Octapharma Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Biotest
13.5.1 Biotest Company Information
13.5.2 Biotest Immune Globulin Intravenous Product Portfolios and Specifications
13.5.3 Biotest Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Biotest Main Business Overview
13.5.5 Biotest Latest Developments
13.6 Kedrion
13.6.1 Kedrion Company Information
13.6.2 Kedrion Immune Globulin Intravenous Product Portfolios and Specifications
13.6.3 Kedrion Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Kedrion Main Business Overview
13.6.5 Kedrion Latest Developments
13.7 Hualan Bio
13.7.1 Hualan Bio Company Information
13.7.2 Hualan Bio Immune Globulin Intravenous Product Portfolios and Specifications
13.7.3 Hualan Bio Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Hualan Bio Main Business Overview
13.7.5 Hualan Bio Latest Developments
13.8 CNBG
13.8.1 CNBG Company Information
13.8.2 CNBG Immune Globulin Intravenous Product Portfolios and Specifications
13.8.3 CNBG Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 CNBG Main Business Overview
13.8.5 CNBG Latest Developments
13.9 Shanghai RAAS
13.9.1 Shanghai RAAS Company Information
13.9.2 Shanghai RAAS Immune Globulin Intravenous Product Portfolios and Specifications
13.9.3 Shanghai RAAS Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Shanghai RAAS Main Business Overview
13.9.5 Shanghai RAAS Latest Developments
13.10 CBPO
13.10.1 CBPO Company Information
13.10.2 CBPO Immune Globulin Intravenous Product Portfolios and Specifications
13.10.3 CBPO Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 CBPO Main Business Overview
13.10.5 CBPO Latest Developments
13.11 LFB Group
13.11.1 LFB Group Company Information
13.11.2 LFB Group Immune Globulin Intravenous Product Portfolios and Specifications
13.11.3 LFB Group Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 LFB Group Main Business Overview
13.11.5 LFB Group Latest Developments
13.12 BPL
13.12.1 BPL Company Information
13.12.2 BPL Immune Globulin Intravenous Product Portfolios and Specifications
13.12.3 BPL Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 BPL Main Business Overview
13.12.5 BPL Latest Developments
13.13 Sichuan Yuanda Shuyang
13.13.1 Sichuan Yuanda Shuyang Company Information
13.13.2 Sichuan Yuanda Shuyang Immune Globulin Intravenous Product Portfolios and Specifications
13.13.3 Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Sichuan Yuanda Shuyang Main Business Overview
13.13.5 Sichuan Yuanda Shuyang Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Immune Globulin Intravenous Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Immune Globulin Intravenous by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Immune Globulin Intravenous by Country/Region, 2019, 2023 & 2030
2.2 Immune Globulin Intravenous Segment by Type
2.2.1 IVIg Liquid
2.2.2 IVIg Powder
2.3 Immune Globulin Intravenous Sales by Type
2.3.1 Global Immune Globulin Intravenous Sales Market Share by Type (2019-2024)
2.3.2 Global Immune Globulin Intravenous Revenue and Market Share by Type (2019-2024)
2.3.3 Global Immune Globulin Intravenous Sale Price by Type (2019-2024)
2.4 Immune Globulin Intravenous Segment by Application
2.4.1 Immunodeficiency
2.4.2 Autoimmune Disease
2.4.3 Acute Infection
2.5 Immune Globulin Intravenous Sales by Application
2.5.1 Global Immune Globulin Intravenous Sale Market Share by Application (2019-2024)
2.5.2 Global Immune Globulin Intravenous Revenue and Market Share by Application (2019-2024)
2.5.3 Global Immune Globulin Intravenous Sale Price by Application (2019-2024)
3 GLOBAL IMMUNE GLOBULIN INTRAVENOUS BY COMPANY
3.1 Global Immune Globulin Intravenous Breakdown Data by Company
3.1.1 Global Immune Globulin Intravenous Annual Sales by Company (2019-2024)
3.1.2 Global Immune Globulin Intravenous Sales Market Share by Company (2019-2024)
3.2 Global Immune Globulin Intravenous Annual Revenue by Company (2019-2024)
3.2.1 Global Immune Globulin Intravenous Revenue by Company (2019-2024)
3.2.2 Global Immune Globulin Intravenous Revenue Market Share by Company (2019-2024)
3.3 Global Immune Globulin Intravenous Sale Price by Company
3.4 Key Manufacturers Immune Globulin Intravenous Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Immune Globulin Intravenous Product Location Distribution
3.4.2 Players Immune Globulin Intravenous Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR IMMUNE GLOBULIN INTRAVENOUS BY GEOGRAPHIC REGION
4.1 World Historic Immune Globulin Intravenous Market Size by Geographic Region (2019-2024)
4.1.1 Global Immune Globulin Intravenous Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Immune Globulin Intravenous Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Immune Globulin Intravenous Market Size by Country/Region (2019-2024)
4.2.1 Global Immune Globulin Intravenous Annual Sales by Country/Region (2019-2024)
4.2.2 Global Immune Globulin Intravenous Annual Revenue by Country/Region (2019-2024)
4.3 Americas Immune Globulin Intravenous Sales Growth
4.4 APAC Immune Globulin Intravenous Sales Growth
4.5 Europe Immune Globulin Intravenous Sales Growth
4.6 Middle East & Africa Immune Globulin Intravenous Sales Growth
5 AMERICAS
5.1 Americas Immune Globulin Intravenous Sales by Country
5.1.1 Americas Immune Globulin Intravenous Sales by Country (2019-2024)
5.1.2 Americas Immune Globulin Intravenous Revenue by Country (2019-2024)
5.2 Americas Immune Globulin Intravenous Sales by Type
5.3 Americas Immune Globulin Intravenous Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Immune Globulin Intravenous Sales by Region
6.1.1 APAC Immune Globulin Intravenous Sales by Region (2019-2024)
6.1.2 APAC Immune Globulin Intravenous Revenue by Region (2019-2024)
6.2 APAC Immune Globulin Intravenous Sales by Type
6.3 APAC Immune Globulin Intravenous Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Immune Globulin Intravenous by Country
7.1.1 Europe Immune Globulin Intravenous Sales by Country (2019-2024)
7.1.2 Europe Immune Globulin Intravenous Revenue by Country (2019-2024)
7.2 Europe Immune Globulin Intravenous Sales by Type
7.3 Europe Immune Globulin Intravenous Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Immune Globulin Intravenous by Country
8.1.1 Middle East & Africa Immune Globulin Intravenous Sales by Country (2019-2024)
8.1.2 Middle East & Africa Immune Globulin Intravenous Revenue by Country (2019-2024)
8.2 Middle East & Africa Immune Globulin Intravenous Sales by Type
8.3 Middle East & Africa Immune Globulin Intravenous Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immune Globulin Intravenous
10.3 Manufacturing Process Analysis of Immune Globulin Intravenous
10.4 Industry Chain Structure of Immune Globulin Intravenous
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Immune Globulin Intravenous Distributors
11.3 Immune Globulin Intravenous Customer
12 WORLD FORECAST REVIEW FOR IMMUNE GLOBULIN INTRAVENOUS BY GEOGRAPHIC REGION
12.1 Global Immune Globulin Intravenous Market Size Forecast by Region
12.1.1 Global Immune Globulin Intravenous Forecast by Region (2025-2030)
12.1.2 Global Immune Globulin Intravenous Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Immune Globulin Intravenous Forecast by Type
12.7 Global Immune Globulin Intravenous Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Immune Globulin Intravenous Product Portfolios and Specifications
13.1.3 Takeda Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Immune Globulin Intravenous Product Portfolios and Specifications
13.2.3 Grifols Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Immune Globulin Intravenous Product Portfolios and Specifications
13.3.3 CSL Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Immune Globulin Intravenous Product Portfolios and Specifications
13.4.3 Octapharma Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Biotest
13.5.1 Biotest Company Information
13.5.2 Biotest Immune Globulin Intravenous Product Portfolios and Specifications
13.5.3 Biotest Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Biotest Main Business Overview
13.5.5 Biotest Latest Developments
13.6 Kedrion
13.6.1 Kedrion Company Information
13.6.2 Kedrion Immune Globulin Intravenous Product Portfolios and Specifications
13.6.3 Kedrion Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Kedrion Main Business Overview
13.6.5 Kedrion Latest Developments
13.7 Hualan Bio
13.7.1 Hualan Bio Company Information
13.7.2 Hualan Bio Immune Globulin Intravenous Product Portfolios and Specifications
13.7.3 Hualan Bio Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Hualan Bio Main Business Overview
13.7.5 Hualan Bio Latest Developments
13.8 CNBG
13.8.1 CNBG Company Information
13.8.2 CNBG Immune Globulin Intravenous Product Portfolios and Specifications
13.8.3 CNBG Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 CNBG Main Business Overview
13.8.5 CNBG Latest Developments
13.9 Shanghai RAAS
13.9.1 Shanghai RAAS Company Information
13.9.2 Shanghai RAAS Immune Globulin Intravenous Product Portfolios and Specifications
13.9.3 Shanghai RAAS Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Shanghai RAAS Main Business Overview
13.9.5 Shanghai RAAS Latest Developments
13.10 CBPO
13.10.1 CBPO Company Information
13.10.2 CBPO Immune Globulin Intravenous Product Portfolios and Specifications
13.10.3 CBPO Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 CBPO Main Business Overview
13.10.5 CBPO Latest Developments
13.11 LFB Group
13.11.1 LFB Group Company Information
13.11.2 LFB Group Immune Globulin Intravenous Product Portfolios and Specifications
13.11.3 LFB Group Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 LFB Group Main Business Overview
13.11.5 LFB Group Latest Developments
13.12 BPL
13.12.1 BPL Company Information
13.12.2 BPL Immune Globulin Intravenous Product Portfolios and Specifications
13.12.3 BPL Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 BPL Main Business Overview
13.12.5 BPL Latest Developments
13.13 Sichuan Yuanda Shuyang
13.13.1 Sichuan Yuanda Shuyang Company Information
13.13.2 Sichuan Yuanda Shuyang Immune Globulin Intravenous Product Portfolios and Specifications
13.13.3 Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Sichuan Yuanda Shuyang Main Business Overview
13.13.5 Sichuan Yuanda Shuyang Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Immune Globulin Intravenous Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Immune Globulin Intravenous Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of IVIg Liquid
Table 4. Major Players of IVIg Powder
Table 5. Global Immune Globulin Intravenous Sales by Type (2019-2024) & (K Units)
Table 6. Global Immune Globulin Intravenous Sales Market Share by Type (2019-2024)
Table 7. Global Immune Globulin Intravenous Revenue by Type (2019-2024) & ($ million)
Table 8. Global Immune Globulin Intravenous Revenue Market Share by Type (2019-2024)
Table 9. Global Immune Globulin Intravenous Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Immune Globulin Intravenous Sales by Application (2019-2024) & (K Units)
Table 11. Global Immune Globulin Intravenous Sales Market Share by Application (2019-2024)
Table 12. Global Immune Globulin Intravenous Revenue by Application (2019-2024)
Table 13. Global Immune Globulin Intravenous Revenue Market Share by Application (2019-2024)
Table 14. Global Immune Globulin Intravenous Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Immune Globulin Intravenous Sales by Company (2019-2024) & (K Units)
Table 16. Global Immune Globulin Intravenous Sales Market Share by Company (2019-2024)
Table 17. Global Immune Globulin Intravenous Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Immune Globulin Intravenous Revenue Market Share by Company (2019-2024)
Table 19. Global Immune Globulin Intravenous Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Immune Globulin Intravenous Producing Area Distribution and Sales Area
Table 21. Players Immune Globulin Intravenous Products Offered
Table 22. Immune Globulin Intravenous Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Immune Globulin Intravenous Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Immune Globulin Intravenous Sales Market Share Geographic Region (2019-2024)
Table 27. Global Immune Globulin Intravenous Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Immune Globulin Intravenous Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Immune Globulin Intravenous Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Immune Globulin Intravenous Sales Market Share by Country/Region (2019-2024)
Table 31. Global Immune Globulin Intravenous Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Immune Globulin Intravenous Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Immune Globulin Intravenous Sales by Country (2019-2024) & (K Units)
Table 34. Americas Immune Globulin Intravenous Sales Market Share by Country (2019-2024)
Table 35. Americas Immune Globulin Intravenous Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Immune Globulin Intravenous Revenue Market Share by Country (2019-2024)
Table 37. Americas Immune Globulin Intravenous Sales by Type (2019-2024) & (K Units)
Table 38. Americas Immune Globulin Intravenous Sales by Application (2019-2024) & (K Units)
Table 39. APAC Immune Globulin Intravenous Sales by Region (2019-2024) & (K Units)
Table 40. APAC Immune Globulin Intravenous Sales Market Share by Region (2019-2024)
Table 41. APAC Immune Globulin Intravenous Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Immune Globulin Intravenous Revenue Market Share by Region (2019-2024)
Table 43. APAC Immune Globulin Intravenous Sales by Type (2019-2024) & (K Units)
Table 44. APAC Immune Globulin Intravenous Sales by Application (2019-2024) & (K Units)
Table 45. Europe Immune Globulin Intravenous Sales by Country (2019-2024) & (K Units)
Table 46. Europe Immune Globulin Intravenous Sales Market Share by Country (2019-2024)
Table 47. Europe Immune Globulin Intravenous Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Immune Globulin Intravenous Revenue Market Share by Country (2019-2024)
Table 49. Europe Immune Globulin Intravenous Sales by Type (2019-2024) & (K Units)
Table 50. Europe Immune Globulin Intravenous Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Immune Globulin Intravenous Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Immune Globulin Intravenous Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Immune Globulin Intravenous Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Immune Globulin Intravenous Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Immune Globulin Intravenous Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Immune Globulin Intravenous Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Immune Globulin Intravenous
Table 58. Key Market Challenges & Risks of Immune Globulin Intravenous
Table 59. Key Industry Trends of Immune Globulin Intravenous
Table 60. Immune Globulin Intravenous Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Immune Globulin Intravenous Distributors List
Table 63. Immune Globulin Intravenous Customer List
Table 64. Global Immune Globulin Intravenous Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Immune Globulin Intravenous Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Immune Globulin Intravenous Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Immune Globulin Intravenous Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Immune Globulin Intravenous Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Immune Globulin Intravenous Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Immune Globulin Intravenous Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Immune Globulin Intravenous Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Immune Globulin Intravenous Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Immune Globulin Intravenous Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Immune Globulin Intravenous Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Immune Globulin Intravenous Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Immune Globulin Intravenous Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Immune Globulin Intravenous Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Takeda Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 79. Takeda Immune Globulin Intravenous Product Portfolios and Specifications
Table 80. Takeda Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Takeda Main Business
Table 82. Takeda Latest Developments
Table 83. Grifols Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 84. Grifols Immune Globulin Intravenous Product Portfolios and Specifications
Table 85. Grifols Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Grifols Main Business
Table 87. Grifols Latest Developments
Table 88. CSL Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 89. CSL Immune Globulin Intravenous Product Portfolios and Specifications
Table 90. CSL Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. CSL Main Business
Table 92. CSL Latest Developments
Table 93. Octapharma Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 94. Octapharma Immune Globulin Intravenous Product Portfolios and Specifications
Table 95. Octapharma Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Octapharma Main Business
Table 97. Octapharma Latest Developments
Table 98. Biotest Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 99. Biotest Immune Globulin Intravenous Product Portfolios and Specifications
Table 100. Biotest Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Biotest Main Business
Table 102. Biotest Latest Developments
Table 103. Kedrion Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 104. Kedrion Immune Globulin Intravenous Product Portfolios and Specifications
Table 105. Kedrion Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Kedrion Main Business
Table 107. Kedrion Latest Developments
Table 108. Hualan Bio Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 109. Hualan Bio Immune Globulin Intravenous Product Portfolios and Specifications
Table 110. Hualan Bio Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Hualan Bio Main Business
Table 112. Hualan Bio Latest Developments
Table 113. CNBG Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 114. CNBG Immune Globulin Intravenous Product Portfolios and Specifications
Table 115. CNBG Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. CNBG Main Business
Table 117. CNBG Latest Developments
Table 118. Shanghai RAAS Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 119. Shanghai RAAS Immune Globulin Intravenous Product Portfolios and Specifications
Table 120. Shanghai RAAS Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Shanghai RAAS Main Business
Table 122. Shanghai RAAS Latest Developments
Table 123. CBPO Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 124. CBPO Immune Globulin Intravenous Product Portfolios and Specifications
Table 125. CBPO Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. CBPO Main Business
Table 127. CBPO Latest Developments
Table 128. LFB Group Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 129. LFB Group Immune Globulin Intravenous Product Portfolios and Specifications
Table 130. LFB Group Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 131. LFB Group Main Business
Table 132. LFB Group Latest Developments
Table 133. BPL Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 134. BPL Immune Globulin Intravenous Product Portfolios and Specifications
Table 135. BPL Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 136. BPL Main Business
Table 137. BPL Latest Developments
Table 138. Sichuan Yuanda Shuyang Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 139. Sichuan Yuanda Shuyang Immune Globulin Intravenous Product Portfolios and Specifications
Table 140. Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 141. Sichuan Yuanda Shuyang Main Business
Table 142. Sichuan Yuanda Shuyang Latest Developments
Table 1. Immune Globulin Intravenous Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Immune Globulin Intravenous Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of IVIg Liquid
Table 4. Major Players of IVIg Powder
Table 5. Global Immune Globulin Intravenous Sales by Type (2019-2024) & (K Units)
Table 6. Global Immune Globulin Intravenous Sales Market Share by Type (2019-2024)
Table 7. Global Immune Globulin Intravenous Revenue by Type (2019-2024) & ($ million)
Table 8. Global Immune Globulin Intravenous Revenue Market Share by Type (2019-2024)
Table 9. Global Immune Globulin Intravenous Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Immune Globulin Intravenous Sales by Application (2019-2024) & (K Units)
Table 11. Global Immune Globulin Intravenous Sales Market Share by Application (2019-2024)
Table 12. Global Immune Globulin Intravenous Revenue by Application (2019-2024)
Table 13. Global Immune Globulin Intravenous Revenue Market Share by Application (2019-2024)
Table 14. Global Immune Globulin Intravenous Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Immune Globulin Intravenous Sales by Company (2019-2024) & (K Units)
Table 16. Global Immune Globulin Intravenous Sales Market Share by Company (2019-2024)
Table 17. Global Immune Globulin Intravenous Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Immune Globulin Intravenous Revenue Market Share by Company (2019-2024)
Table 19. Global Immune Globulin Intravenous Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Immune Globulin Intravenous Producing Area Distribution and Sales Area
Table 21. Players Immune Globulin Intravenous Products Offered
Table 22. Immune Globulin Intravenous Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Immune Globulin Intravenous Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Immune Globulin Intravenous Sales Market Share Geographic Region (2019-2024)
Table 27. Global Immune Globulin Intravenous Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Immune Globulin Intravenous Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Immune Globulin Intravenous Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Immune Globulin Intravenous Sales Market Share by Country/Region (2019-2024)
Table 31. Global Immune Globulin Intravenous Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Immune Globulin Intravenous Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Immune Globulin Intravenous Sales by Country (2019-2024) & (K Units)
Table 34. Americas Immune Globulin Intravenous Sales Market Share by Country (2019-2024)
Table 35. Americas Immune Globulin Intravenous Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Immune Globulin Intravenous Revenue Market Share by Country (2019-2024)
Table 37. Americas Immune Globulin Intravenous Sales by Type (2019-2024) & (K Units)
Table 38. Americas Immune Globulin Intravenous Sales by Application (2019-2024) & (K Units)
Table 39. APAC Immune Globulin Intravenous Sales by Region (2019-2024) & (K Units)
Table 40. APAC Immune Globulin Intravenous Sales Market Share by Region (2019-2024)
Table 41. APAC Immune Globulin Intravenous Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Immune Globulin Intravenous Revenue Market Share by Region (2019-2024)
Table 43. APAC Immune Globulin Intravenous Sales by Type (2019-2024) & (K Units)
Table 44. APAC Immune Globulin Intravenous Sales by Application (2019-2024) & (K Units)
Table 45. Europe Immune Globulin Intravenous Sales by Country (2019-2024) & (K Units)
Table 46. Europe Immune Globulin Intravenous Sales Market Share by Country (2019-2024)
Table 47. Europe Immune Globulin Intravenous Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Immune Globulin Intravenous Revenue Market Share by Country (2019-2024)
Table 49. Europe Immune Globulin Intravenous Sales by Type (2019-2024) & (K Units)
Table 50. Europe Immune Globulin Intravenous Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Immune Globulin Intravenous Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Immune Globulin Intravenous Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Immune Globulin Intravenous Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Immune Globulin Intravenous Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Immune Globulin Intravenous Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Immune Globulin Intravenous Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Immune Globulin Intravenous
Table 58. Key Market Challenges & Risks of Immune Globulin Intravenous
Table 59. Key Industry Trends of Immune Globulin Intravenous
Table 60. Immune Globulin Intravenous Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Immune Globulin Intravenous Distributors List
Table 63. Immune Globulin Intravenous Customer List
Table 64. Global Immune Globulin Intravenous Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Immune Globulin Intravenous Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Immune Globulin Intravenous Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Immune Globulin Intravenous Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Immune Globulin Intravenous Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Immune Globulin Intravenous Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Immune Globulin Intravenous Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Immune Globulin Intravenous Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Immune Globulin Intravenous Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Immune Globulin Intravenous Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Immune Globulin Intravenous Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Immune Globulin Intravenous Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Immune Globulin Intravenous Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Immune Globulin Intravenous Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Takeda Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 79. Takeda Immune Globulin Intravenous Product Portfolios and Specifications
Table 80. Takeda Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Takeda Main Business
Table 82. Takeda Latest Developments
Table 83. Grifols Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 84. Grifols Immune Globulin Intravenous Product Portfolios and Specifications
Table 85. Grifols Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Grifols Main Business
Table 87. Grifols Latest Developments
Table 88. CSL Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 89. CSL Immune Globulin Intravenous Product Portfolios and Specifications
Table 90. CSL Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. CSL Main Business
Table 92. CSL Latest Developments
Table 93. Octapharma Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 94. Octapharma Immune Globulin Intravenous Product Portfolios and Specifications
Table 95. Octapharma Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Octapharma Main Business
Table 97. Octapharma Latest Developments
Table 98. Biotest Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 99. Biotest Immune Globulin Intravenous Product Portfolios and Specifications
Table 100. Biotest Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Biotest Main Business
Table 102. Biotest Latest Developments
Table 103. Kedrion Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 104. Kedrion Immune Globulin Intravenous Product Portfolios and Specifications
Table 105. Kedrion Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Kedrion Main Business
Table 107. Kedrion Latest Developments
Table 108. Hualan Bio Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 109. Hualan Bio Immune Globulin Intravenous Product Portfolios and Specifications
Table 110. Hualan Bio Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Hualan Bio Main Business
Table 112. Hualan Bio Latest Developments
Table 113. CNBG Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 114. CNBG Immune Globulin Intravenous Product Portfolios and Specifications
Table 115. CNBG Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. CNBG Main Business
Table 117. CNBG Latest Developments
Table 118. Shanghai RAAS Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 119. Shanghai RAAS Immune Globulin Intravenous Product Portfolios and Specifications
Table 120. Shanghai RAAS Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Shanghai RAAS Main Business
Table 122. Shanghai RAAS Latest Developments
Table 123. CBPO Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 124. CBPO Immune Globulin Intravenous Product Portfolios and Specifications
Table 125. CBPO Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. CBPO Main Business
Table 127. CBPO Latest Developments
Table 128. LFB Group Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 129. LFB Group Immune Globulin Intravenous Product Portfolios and Specifications
Table 130. LFB Group Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 131. LFB Group Main Business
Table 132. LFB Group Latest Developments
Table 133. BPL Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 134. BPL Immune Globulin Intravenous Product Portfolios and Specifications
Table 135. BPL Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 136. BPL Main Business
Table 137. BPL Latest Developments
Table 138. Sichuan Yuanda Shuyang Basic Information, Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 139. Sichuan Yuanda Shuyang Immune Globulin Intravenous Product Portfolios and Specifications
Table 140. Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 141. Sichuan Yuanda Shuyang Main Business
Table 142. Sichuan Yuanda Shuyang Latest Developments
LIST OF FIGURES
Figure 1. Picture of Immune Globulin Intravenous
Figure 2. Immune Globulin Intravenous Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immune Globulin Intravenous Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Immune Globulin Intravenous Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Immune Globulin Intravenous Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of IVIg Liquid
Figure 10. Product Picture of IVIg Powder
Figure 11. Global Immune Globulin Intravenous Sales Market Share by Type in 2023
Figure 12. Global Immune Globulin Intravenous Revenue Market Share by Type (2019-2024)
Figure 13. Immune Globulin Intravenous Consumed in Immunodeficiency
Figure 14. Global Immune Globulin Intravenous Market: Immunodeficiency (2019-2024) & (K Units)
Figure 15. Immune Globulin Intravenous Consumed in Autoimmune Disease
Figure 16. Global Immune Globulin Intravenous Market: Autoimmune Disease (2019-2024) & (K Units)
Figure 17. Immune Globulin Intravenous Consumed in Acute Infection
Figure 18. Global Immune Globulin Intravenous Market: Acute Infection (2019-2024) & (K Units)
Figure 19. Global Immune Globulin Intravenous Sales Market Share by Application (2023)
Figure 20. Global Immune Globulin Intravenous Revenue Market Share by Application in 2023
Figure 21. Immune Globulin Intravenous Sales Market by Company in 2023 (K Units)
Figure 22. Global Immune Globulin Intravenous Sales Market Share by Company in 2023
Figure 23. Immune Globulin Intravenous Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Immune Globulin Intravenous Revenue Market Share by Company in 2023
Figure 25. Global Immune Globulin Intravenous Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Immune Globulin Intravenous Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Immune Globulin Intravenous Sales 2019-2024 (K Units)
Figure 28. Americas Immune Globulin Intravenous Revenue 2019-2024 ($ Millions)
Figure 29. APAC Immune Globulin Intravenous Sales 2019-2024 (K Units)
Figure 30. APAC Immune Globulin Intravenous Revenue 2019-2024 ($ Millions)
Figure 31. Europe Immune Globulin Intravenous Sales 2019-2024 (K Units)
Figure 32. Europe Immune Globulin Intravenous Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Immune Globulin Intravenous Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Immune Globulin Intravenous Revenue 2019-2024 ($ Millions)
Figure 35. Americas Immune Globulin Intravenous Sales Market Share by Country in 2023
Figure 36. Americas Immune Globulin Intravenous Revenue Market Share by Country in 2023
Figure 37. Americas Immune Globulin Intravenous Sales Market Share by Type (2019-2024)
Figure 38. Americas Immune Globulin Intravenous Sales Market Share by Application (2019-2024)
Figure 39. United States Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Immune Globulin Intravenous Sales Market Share by Region in 2023
Figure 44. APAC Immune Globulin Intravenous Revenue Market Share by Regions in 2023
Figure 45. APAC Immune Globulin Intravenous Sales Market Share by Type (2019-2024)
Figure 46. APAC Immune Globulin Intravenous Sales Market Share by Application (2019-2024)
Figure 47. China Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Immune Globulin Intravenous Sales Market Share by Country in 2023
Figure 55. Europe Immune Globulin Intravenous Revenue Market Share by Country in 2023
Figure 56. Europe Immune Globulin Intravenous Sales Market Share by Type (2019-2024)
Figure 57. Europe Immune Globulin Intravenous Sales Market Share by Application (2019-2024)
Figure 58. Germany Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Immune Globulin Intravenous Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Immune Globulin Intravenous Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Immune Globulin Intravenous Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Immune Globulin Intravenous Sales Market Share by Application (2019-2024)
Figure 67. Egypt Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Immune Globulin Intravenous in 2023
Figure 73. Manufacturing Process Analysis of Immune Globulin Intravenous
Figure 74. Industry Chain Structure of Immune Globulin Intravenous
Figure 75. Channels of Distribution
Figure 76. Global Immune Globulin Intravenous Sales Market Forecast by Region (2025-2030)
Figure 77. Global Immune Globulin Intravenous Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Immune Globulin Intravenous Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Immune Globulin Intravenous Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Immune Globulin Intravenous Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Immune Globulin Intravenous Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Immune Globulin Intravenous
Figure 2. Immune Globulin Intravenous Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immune Globulin Intravenous Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Immune Globulin Intravenous Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Immune Globulin Intravenous Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of IVIg Liquid
Figure 10. Product Picture of IVIg Powder
Figure 11. Global Immune Globulin Intravenous Sales Market Share by Type in 2023
Figure 12. Global Immune Globulin Intravenous Revenue Market Share by Type (2019-2024)
Figure 13. Immune Globulin Intravenous Consumed in Immunodeficiency
Figure 14. Global Immune Globulin Intravenous Market: Immunodeficiency (2019-2024) & (K Units)
Figure 15. Immune Globulin Intravenous Consumed in Autoimmune Disease
Figure 16. Global Immune Globulin Intravenous Market: Autoimmune Disease (2019-2024) & (K Units)
Figure 17. Immune Globulin Intravenous Consumed in Acute Infection
Figure 18. Global Immune Globulin Intravenous Market: Acute Infection (2019-2024) & (K Units)
Figure 19. Global Immune Globulin Intravenous Sales Market Share by Application (2023)
Figure 20. Global Immune Globulin Intravenous Revenue Market Share by Application in 2023
Figure 21. Immune Globulin Intravenous Sales Market by Company in 2023 (K Units)
Figure 22. Global Immune Globulin Intravenous Sales Market Share by Company in 2023
Figure 23. Immune Globulin Intravenous Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Immune Globulin Intravenous Revenue Market Share by Company in 2023
Figure 25. Global Immune Globulin Intravenous Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Immune Globulin Intravenous Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Immune Globulin Intravenous Sales 2019-2024 (K Units)
Figure 28. Americas Immune Globulin Intravenous Revenue 2019-2024 ($ Millions)
Figure 29. APAC Immune Globulin Intravenous Sales 2019-2024 (K Units)
Figure 30. APAC Immune Globulin Intravenous Revenue 2019-2024 ($ Millions)
Figure 31. Europe Immune Globulin Intravenous Sales 2019-2024 (K Units)
Figure 32. Europe Immune Globulin Intravenous Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Immune Globulin Intravenous Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Immune Globulin Intravenous Revenue 2019-2024 ($ Millions)
Figure 35. Americas Immune Globulin Intravenous Sales Market Share by Country in 2023
Figure 36. Americas Immune Globulin Intravenous Revenue Market Share by Country in 2023
Figure 37. Americas Immune Globulin Intravenous Sales Market Share by Type (2019-2024)
Figure 38. Americas Immune Globulin Intravenous Sales Market Share by Application (2019-2024)
Figure 39. United States Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Immune Globulin Intravenous Sales Market Share by Region in 2023
Figure 44. APAC Immune Globulin Intravenous Revenue Market Share by Regions in 2023
Figure 45. APAC Immune Globulin Intravenous Sales Market Share by Type (2019-2024)
Figure 46. APAC Immune Globulin Intravenous Sales Market Share by Application (2019-2024)
Figure 47. China Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Immune Globulin Intravenous Sales Market Share by Country in 2023
Figure 55. Europe Immune Globulin Intravenous Revenue Market Share by Country in 2023
Figure 56. Europe Immune Globulin Intravenous Sales Market Share by Type (2019-2024)
Figure 57. Europe Immune Globulin Intravenous Sales Market Share by Application (2019-2024)
Figure 58. Germany Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Immune Globulin Intravenous Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Immune Globulin Intravenous Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Immune Globulin Intravenous Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Immune Globulin Intravenous Sales Market Share by Application (2019-2024)
Figure 67. Egypt Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Immune Globulin Intravenous Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Immune Globulin Intravenous in 2023
Figure 73. Manufacturing Process Analysis of Immune Globulin Intravenous
Figure 74. Industry Chain Structure of Immune Globulin Intravenous
Figure 75. Channels of Distribution
Figure 76. Global Immune Globulin Intravenous Sales Market Forecast by Region (2025-2030)
Figure 77. Global Immune Globulin Intravenous Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Immune Globulin Intravenous Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Immune Globulin Intravenous Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Immune Globulin Intravenous Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Immune Globulin Intravenous Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Duck Virus Enteritis Vaccine Market Growth 2024-2030
US$ 3,660.00
March 2024
95 pages
Global Cardiac Resynchronisation Therapy (CRT) Device Market Growth 2023-2029
US$ 3,660.00
February 2023
92 pages
Global Veterinary Vaccine Market Growth 2025-2031
US$ 3,660.00
December 2024
164 pages
Global Pre-Filled Saline Syringe Market Growth 2025-2031
US$ 3,660.00
January 2025
95 pages
